382 filings
Page 12 of 20
8-K
21yz2
8 Dec 09
Changes in Registrant's Certifying Accountant
12:00am
8-K
nglk8k4422us0dbbt
13 Nov 09
Regulation FD Disclosure
12:00am
8-K
eihg1g0kk 7c
12 Nov 09
Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update; Zevalin® Sales Up 80% Over Third Quarter 2008
12:00am
8-K
fhl8gcmrzg v1ti
10 Nov 09
Spectrum Pharmaceuticals and Nippon Kayaku Enter Collaboration Agreement for Apaziquone In Asian Territories
12:00am
8-K
dabz71lcversw t9lhco
9 Oct 09
Spectrum Pharmaceuticals Receives Complete Response Letter from Fda for Fusilev® In Advanced Metastatic Colorectal Cancer
12:00am
8-K
vv8ehldoj 0af
23 Sep 09
Entry into a Material Definitive Agreement
12:00am
8-K
m876ew
4 Sep 09
Fda Approves Zevalin® Expanded Label As Part of First-line Therapy In Treatment of Follicular Non-hodgkin’s Lymphoma
12:00am
8-K
w86xt9fwht8osbuo1
13 Aug 09
Spectrum Pharmaceuticals Announces Second Quarter 2009 Corporate Update
12:00am
8-K
9bzhjgpq7ey2sqphmcid
2 Jul 09
Entry into a Material Definitive Agreement
12:00am
8-K
kmx70req4jahkb
2 Jul 09
Departure of Directors or Certain Officers
12:00am
8-K
8yez0p6qsur77
18 Jun 09
Entry into a Material Definitive Agreement
12:00am
8-K/A
ca5yx 88uai1
29 May 09
Financial Statements and Exhibits
12:00am
8-K
ygg9xfyg9biga2l83e11
28 May 09
Entry into a Material Definitive Agreement
12:00am
8-K
zmxso ztc7eb1
18 May 09
Spectrum Pharmaceuticals Announces First Quarter 2009 Corporate Update and Pipeline Review
12:00am
8-K
ij0fhhbap8f f8
7 May 09
Entry into a Material Definitive Agreement
12:00am
8-K
qrr05jui8q2qy1433fd3
31 Mar 09
Spectrum Pharmaceuticals Announces Fiscal Year 2008 Corporate Update and Pipeline Review
12:00am
8-K
m5odrmutir el1a
19 Mar 09
Spectrum Pharmaceuticals Acquires 100% of Zevalin®, an Fda-approved, Proprietary, Biological Drug for Non-hodgkin’s Lymphoma
12:00am
8-K/A
6eynxecqahxhd5
3 Mar 09
Results of Operations and Financial Condition
12:00am
8-K/A
zglx6kvt7tcq xi1tz
2 Mar 09
Financial Statements and Exhibits
12:00am
8-K
3b8 3ifnh7
26 Feb 09
Spectrum Pharmaceuticals Poised to Acquire 100% Interest In Rit Oncology LLC™ Joint Venture Upon Cti’s Fulfillment of Closing Conditions
12:00am